Compare MLTX & MUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MLTX | MUX |
|---|---|---|
| Founded | 2021 | 1979 |
| Country | Switzerland | Canada |
| Employees | N/A | 1432 |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.6B |
| IPO Year | 2020 | N/A |
| Metric | MLTX | MUX |
|---|---|---|
| Price | $19.93 | $18.05 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 4 |
| Target Price | ★ $27.50 | $26.63 |
| AVG Volume (30 Days) | 1.4M | ★ 1.5M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $37.86 |
| Revenue Next Year | N/A | $31.10 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.95 | $9.82 |
| 52 Week High | $62.75 | $29.70 |
| Indicator | MLTX | MUX |
|---|---|---|
| Relative Strength Index (RSI) | 55.88 | 43.39 |
| Support Level | $15.54 | $17.41 |
| Resistance Level | $21.00 | $18.46 |
| Average True Range (ATR) | 1.06 | 0.86 |
| MACD | -0.11 | 0.10 |
| Stochastic Oscillator | 27.74 | 38.27 |
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.
McEwen Inc, formerly McEwen Mining Inc is a mining and minerals production and exploration company that focuses on precious and base minerals in Argentina, Mexico, and the United States. The company generates its revenue from gold and silver production. It owns and operates the wholly-owned El Gallo 1 mine in Mexico and holds a minority stake in the company that manages the San Jose mine in Argentina. More than half of the company's gold output comes from the El Gallo 1 mine, while the remaining gold production and the majority of silver production are sourced from the San Jose mine. Geographically, majority of production occurs in the United States.